Skip To Main Content
John Manns on Muck Rack

John Manns

Durham
As seen in: Pharma's Almanac
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to John Manns’s profile

Articles by John Manns

Closing the Gender Gap in Clinical Research

|
By Rose Blackburne, Davide Garrisi, John Manns
| Pharma's Almanac Verified
In previous decades, women, including pregnant and lactating women, were significantly underrepresented in clinical trials, and trials investigating diseases exclusive to women were particularly rare. Even today, investments in non-oncologic conditions that affect women’s health account for a smaller portion of total clinical development investments.1 Recruitment and retention challenges unique to women — and to specific populations of women — are a contributing factor.
Open in Who Shared Issue with article?

New Clinical Frontiers in Neuroscience

|
By John Manns, Sabine Krofczik-Wilhelm
| Pharma's Almanac Verified
The COVID-19 pandemic has highlighted the need for evolution and flexibility in clinical research, particularly in the area of neuroscience. As a result, the industry has turned its attention to hybrid and decentralized clinical trials (DCTs) to protect current research endeavors while incorporating agile options in future protocols.
Open in Who Shared Issue with article?

Modern Strategies for Dermatology Clinical Trials

|
By Tim Rich Verified, Rose Blackburne, John Manns, Michael Noss
| Pharma's Almanac Verified
To be most successful, dermatology clinical trials should be accessible to a diverse array of qualified patients and designed to encourage patient participation. These trials should also reduce the patient and investigator site burdens, reduce start-up and enrollment timelines, and ensure consistent, high-quality assessments and data collection.
Open in Who Shared Issue with article?
Show More